<VariationArchive VariationID="2422562" VariationName="NC_000012.11:g.(?_114793337)_(114837457_?)del" VariationType="Deletion" Accession="VCV002422562" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1938875" VariationID="2422562">
      <GeneList>
        <Gene Symbol="TBX5" FullName="T-box transcription factor 5" GeneID="6910" HGNC_ID="HGNC:11604" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="114353911" stop="114408442" display_start="114353911" display_stop="114408442" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="114791734" stop="114846246" display_start="114791734" display_stop="114846246" Strand="-" />
          </Location>
          <OMIM>601620</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TBX5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TBX5">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000012.11:g.(?_114793337)_(114837457_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q24.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" innerStart="114793337" innerStop="114837457" display_start="114793337" display_stop="114837457" variantLength="44121" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.(?_114793337)_(114837457_?)del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.(?_114793337)_(114837457_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000012.11:g.(?_114793337)_(114837457_?)del AND Aortic valve disease 2" Accession="RCV003122156" Version="4">
        <ClassifiedConditionList TraitSetID="8857">
          <ClassifiedCondition DB="MedGen" ID="C3542024">Aortic valve disease 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="8857" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17368" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aortic valve disease 2</ElementValue>
                <XRef ID="MONDO:0013902" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AOVD2</ElementValue>
                <XRef Type="MIM" ID="614823" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18471" />
                <XRef ID="18471" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C3542024" DB="MedGen" />
              <XRef ID="MONDO:0013902" DB="MONDO" />
              <XRef Type="MIM" ID="614823" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7071339" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_000192.3_12_Deletion (exons 4-9)|MedGen:CN143724" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003790840" DateUpdated="2024-06-09" DateCreated="2023-02-13" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the TBX5 protein in which other variant(s) (p.Tyr368*) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with TBX5-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 4-9 of the TBX5 gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBX5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.(?_114793337)_(114837457_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN143724" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7071339" TraitType="Disease" MappingType="XRef" MappingValue="CN143724" MappingRef="MedGen">
        <MedGen CUI="C3542024" Name="Aortic valve disease 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

